Identification of pancreatic adenocarcinoma molecular subtypes on histology slides using deep learning models.
Charlie Saillard(Laboratoire Procédés et Ingénierie en Mécanique et Matériaux), Jérôme Cros(Université Paris Cité), Benoît Schmauch(Owl Research Institute), Cindy Neuzillet, Louis de Mestier(Inserm), Magali Svrcek(Azienda Unita' Sanitaria Locale Di Modena), Aurélie Kamoun(La Ligue Contre le Cancer), Pierre Courtiol, Rémy Nicolle(Centre National de la Recherche Scientifique), F. Delecourt(Inserm), Mikhail Zaslavskiy, Dusetti J. Nelson(Inserm), Valérie Paradis(Centre National de la Recherche Scientifique), Jean‐Baptiste Bachet(Université Paris Cité), Juan Iovanna(Centre National de la Recherche Scientifique), Pascal Hammel(Université Paris Cité), Jean‐François Emile(Université de Versailles Saint-Quentin-en-Yvelines), Mira Ayadi(IntegraGen (France)), Olivier Moindrot, Armelle Bardier–Dupas(Sorbonne Université)
Cited by 1
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2021|1.3k
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
|New England Journal of Medicine|1996|878